Abstract: . . .  1998;66:5337-43. 93. Herzberg MC, MacFarlane GD, Gong K. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immun 1992;60:4809-18. 94. Imamura T, Potempa J, Tanase S, Travis J. Activation of blood coagulation fac- tor X by anginase-specific cysteine proteinase (gingipain-Rs) from Porphy- romonas gingivalis . J Biol Chem 1997;272:16062-7. 95. Herzberg MC, Meyer MW. Dental plaque, platelets and cardiovascular disease . Ann Periodontol 1998;3:151-60. Fong 56 JAMC 11 JUILL. 2000; 163 (1) Reprint requests to: Dr. Ignatius W. Fong, Division of Infectious Diseases , Rm. 4179V, St. Michaels . . .
. . .  of patients suf- fering from grade III atherosclerosis. Am J Pathol 1990;136:23-8. 25. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-4. 26. Speir E, Yu ZX, Ferrans VJ. Infectious agents in coronary artery disease : viral infection, aspirin and gene expression in human coronary smooth muscle cells. Rev Port Cardiol 1998;17(Suppl 2):II33-9. 27. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Sci- ence 1994;265:391-4. 28. Jacob HS, Viscer M, Kay NS, Goodman JL, Moldow CF, Vercellotti . . .
. . .  a link between periodontal disease and coro- nary heart disease ? Br Dent J 1998;184:33-8. 89. Joshipura KJ, Douglass CW, Willett WC. Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol 1998;3:175-83. 90. Lowe GDO, Kweider M, Murray GD, Kinase D, McGowan DA. Fibrinogen and dental disease a coronary risk factor. In: Ernst E, Koenig W, Lowe GDO, Meade T, editors. Fibrinogen a new cardiovascular risk factor . Oxford: Blackwell; 1992. p. 187-91. 91. Matilla KJ, Rasi V, Nieminen M. Von Willebrand factor antigen and dental in- fections. Thromb Res 1989;56:325-91. 92. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial . . .
. . .  Sorlie P, Chombless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1998;98:845-50. 78. Khurshid A, Fenske T, Bajwa T, Bourgeois K, Vakil N. A prospective, con- trolled study of Helicobacter pylori seroprevalence in coronary artery disease . Am J Gastroenterol 1998;93:717-20. 79. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34:2766-9. 80. Danesh J, Koreth J, Youngman L, Collins R, Arnold J, Balarajan Y, . . .
--3000,4,375,3295,52593